Home
Matthew T. Wiley, Chief Commercial Officer: BioXcel Therapeutics BTAIQ Sell · Filed 24/09/17
Trade details
- Type
- Insider sale
- Amount
- $148.35
- Shares · price
- 215 sh · $0.69 a share
- Held after
- 4,033 sh
- Trade date
- 24/09/16
- Filed
- 24/09/17
- Days to filing
- 1 days
Sold 5.1% of holdings
- Share of holding sold
- 5.1%
BioXcel Therapeutics trades, last 26 weeks
What else happened in BioXcel Therapeutics around then
Filed or reported within 30 days of the trade day · 24/08/17~24/10/16Matthew T. Wiley's recent trades
- Matthew T. Wiley
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$113.3K
3,097 sh
$113.3K
Filed 09/29
Traded 09/25
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$113.8K
3,097 sh
$113.8K
Filed 09/25
Traded 09/25
- Matthew T. Wiley
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$129.1K
2,867 sh
$129.1K
Filed 06/26
Traded 06/25
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$120.8K
2,867 sh
$120.8K
Filed 06/25
Traded 06/25
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$3,450
6,272 sh
$3,450
Filed 24/10/03
Traded 24/10/03
